Literature DB >> 25476661

Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma.

Hye Jeong Kim1, Ji In Lee, Yoon Young Cho, Soo Youn Lee, Jung Han Kim, Byong Chang Jung, Sun Wook Kim, Jae Hoon Chung, Yong-Ki Min, Myung-Shik Lee, Moon-Kyu Lee, Jae Hyeon Kim.   

Abstract

The aim of this study was to determine the diagnostic efficacy of free metanephrines in plasma samples drawn in the seated position compared with 24-h urinary metanephrines in detecting pheochromocytomas in Asian patients. This prospective study was conducted at Samsung Medical Center between May 2010 and July 2011. The study contained 245 subjects, including 28 patients with histologically-proven pheochromocytoma, 44 with histologically-proven non-pheochromocytoma, 112 controls suspected of having tumors but with negative investigations during two or more years of follow-up, and 45 healthy normotensive volunteers. Plasma-free metanephrines were measured by LC-MS/MS. The cut-off values with optimal sensitivity and specificity for plasma metanephrine and plasma normetanephrine were 0.33 nmol/L and 0.61 nmol/L, respectively. Both the plasma metanephrines measurement and urinary metanephrines measurement had a sensitivity of 96.4% (p = 1.00). However, the urinary metanephrines measurement was significantly more specific than the plasma metanephrines measurement (94.2% vs. 75.6%; p < 0.001). When we applied cut-off values based on BMI, specificity improved from 75.6% to 87.2%, with a comparable gain in sensitivity. From a diagnostic perspective, measurement of free metanephrines in plasma drawn in the seated position is highly sensitive but insufficiently specific when compared with measurement of 24-h urinary fractionated metanephrines. The specificity may be improved by applying cut-off values based on BMI. We suggest that free metanephrines in plasma drawn from seated position can also be used as an initial screening test to ensure that pheochromocytomas are not missed in Asian patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25476661     DOI: 10.1507/endocrj.EJ14-0384

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

Review 1.  Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Authors:  Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 2.  The role of miRNAs in the pheochromocytomas.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-10-13

3.  Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.

Authors:  Dipti Rao; Mirko Peitzsch; Aleksander Prejbisz; Katarzyna Hanus; Martin Fassnacht; Felix Beuschlein; Christina Brugger; Stephanie Fliedner; Katharina Langton; Christina Pamporaki; Volker Gudziol; Anthony Stell; Andrzej Januszewicz; Henri J L M Timmers; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Eur J Endocrinol       Date:  2017-05-05       Impact factor: 6.664

4.  Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.

Authors:  Eu Jeong Ku; Kyoung Jin Kim; Jung Hee Kim; Mi Kyung Kim; Chang Ho Ahn; Kyung Ae Lee; Seung Hun Lee; You-Bin Lee; Kyeong Hye Park; Yun Mi Choi; Namki Hong; A Ram Hong; Sang-Wook Kang; Byung Kwan Park; Moon-Woo Seong; Myungshin Kim; Kyeong Cheon Jung; Chan Kwon Jung; Young Seok Cho; Jin Chul Paeng; Jae Hyeon Kim; Ohk-Hyun Ryu; Yumie Rhee; Chong Hwa Kim; Eun Jig Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-06

5.  Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.

Authors:  Jiyeon Ahn; Ji Yun Park; Gyuri Kim; Sang-Man Jin; Kyu Yeon Hur; Soo-Youn Lee; Jae Hyeon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.